Demir, Ö
Ieong, P U
Amaro, R E
Article History
Received: 2 June 2016
Accepted: 15 July 2016
First Online: 19 September 2016
Competing interests
: REA is a co-founder of Actavalon Inc., a company developing p53 reactivation compounds for anticancer therapeutics.